Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2

Sponsor Class

NIH 2

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Gynecologic 2Breast 2Endocrine 1

Conditions

Endometrial Neoplasms 2

Interventions

Paclitaxel 77Carboplatin 71Cisplatin 70Radiotherapy 27Bevacizumab 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 18Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 14liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Taxes 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Cytoreduction Surgical Procedures 7Albumin-Bound Paclitaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Reverse Transcriptase Polymerase Chain Reaction × Gynecologic × Clear all
NCT01150682 2011-04-29

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

National Cancer Institute (NCI)

Unknown
865 enrolled
Gynecologic

Endometrial Neoplasms

NCT01119573 2010-06-22

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

National Cancer Institute (NCI)

Unknown
100 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡